St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

Recruiting now · Not applicable

Conditions studied: Cervical Cancer Screening

In brief

This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.

Key facts

Study ID

NCT05092022

Run by

Milton S. Hershey Medical Center

People needed

50

Starts

2023-09-18

Expected to finish

2026-12-31

Last updated by the study team

2026-07-06

Who can join

Age: 30 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Eligible but out-of-date for cervical cancer screening
• Able to speak, read, and communicate well in English or Spanish
• Not at greater than average risk for cervical cancer

You may not qualify if…

• Pregnant
• Incarcerated
• Greater than average risk for cervical cancer, for example:
• Already diagnosed with high-grade precancerous cervical cancer or cervical lesions
• Has a compromised immune system
• Unable to speak, read, and communicate well in English or Spanish
• Unable or unwilling to give implied consent or otherwise complete study requirements

Where it is running

• Penn State Health St. Joseph's — Reading, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.